Estradiol benzoate decreases nigral GABAergic activity in male rats

Ferdinando Nicoletti, James L. Meek

Research output: Contribution to journalArticle

Abstract

Repeated doses of estradiol benzoate (10 μg/kg, s.c., once a day for 2, 5 or 8 days) to male rats decreased γ-aminobutyric acid (GABA) content and glutamate decarboxylase (GAD) activity in substantia nigra (SN) but failed to change these parameters in hippocampus, cerebral cortex, cerebellum, lateral septum and olfactory tubercle. In the caudate nucleus, estradiol benzoate decreased GABA concentration but did not modify GAD activity. A decrease in nigral GABA concentration and GAD activity was also observed 24 and 48 but not 3 h after a single injection of estradiol benzoate. These data are consistent with results on GAD activity reported by McGinnis et al.26 in ovariectomized rats. Kinetic analysis of nigral GAD activity revealed that repeated estradiol benzoate injection reduced the Vmax without affecting the Km of GAD. Estradiol benzoate also reduced the rate of nigral GABA accumulation resulting from local infusion of gabaculine, suggesting that the steroid decreases GABA turnover in male rat SN. Hypophysectomy decreased GABA content and GAD activity in SN and GABA content in striatum. Administration of estradiol benzoate for 8 days to hypophysectomized rats failed to decrease further these parameters. Taken together, these data suggest that estradiol benzoate decreases SN GABAergic activity and that the integrity of the pituitary gland is required for this effect.

Original languageEnglish
Pages (from-to)179-183
Number of pages5
JournalBrain Research
Volume332
Issue number1
DOIs
Publication statusPublished - Apr 15 1985

Fingerprint

Glutamate Decarboxylase
Substantia Nigra
gamma-Aminobutyric Acid
Aminobutyrates
Hypophysectomy
Injections
Caudate Nucleus
Pituitary Gland
estradiol 3-benzoate
Cerebral Cortex
Cerebellum
Hippocampus
Steroids

Keywords

  • estradiol benzoate
  • gabaculine
  • glutamate decarboxylase (GAD) activity
  • hypophysectomy
  • substantia nigra
  • γ-aminobutyric acid (GABA) activity

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Estradiol benzoate decreases nigral GABAergic activity in male rats. / Nicoletti, Ferdinando; Meek, James L.

In: Brain Research, Vol. 332, No. 1, 15.04.1985, p. 179-183.

Research output: Contribution to journalArticle

@article{97f0a022de504d8e9ca68c0cbd1504da,
title = "Estradiol benzoate decreases nigral GABAergic activity in male rats",
abstract = "Repeated doses of estradiol benzoate (10 μg/kg, s.c., once a day for 2, 5 or 8 days) to male rats decreased γ-aminobutyric acid (GABA) content and glutamate decarboxylase (GAD) activity in substantia nigra (SN) but failed to change these parameters in hippocampus, cerebral cortex, cerebellum, lateral septum and olfactory tubercle. In the caudate nucleus, estradiol benzoate decreased GABA concentration but did not modify GAD activity. A decrease in nigral GABA concentration and GAD activity was also observed 24 and 48 but not 3 h after a single injection of estradiol benzoate. These data are consistent with results on GAD activity reported by McGinnis et al.26 in ovariectomized rats. Kinetic analysis of nigral GAD activity revealed that repeated estradiol benzoate injection reduced the Vmax without affecting the Km of GAD. Estradiol benzoate also reduced the rate of nigral GABA accumulation resulting from local infusion of gabaculine, suggesting that the steroid decreases GABA turnover in male rat SN. Hypophysectomy decreased GABA content and GAD activity in SN and GABA content in striatum. Administration of estradiol benzoate for 8 days to hypophysectomized rats failed to decrease further these parameters. Taken together, these data suggest that estradiol benzoate decreases SN GABAergic activity and that the integrity of the pituitary gland is required for this effect.",
keywords = "estradiol benzoate, gabaculine, glutamate decarboxylase (GAD) activity, hypophysectomy, substantia nigra, γ-aminobutyric acid (GABA) activity",
author = "Ferdinando Nicoletti and Meek, {James L.}",
year = "1985",
month = "4",
day = "15",
doi = "10.1016/0006-8993(85)90404-4",
language = "English",
volume = "332",
pages = "179--183",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Estradiol benzoate decreases nigral GABAergic activity in male rats

AU - Nicoletti, Ferdinando

AU - Meek, James L.

PY - 1985/4/15

Y1 - 1985/4/15

N2 - Repeated doses of estradiol benzoate (10 μg/kg, s.c., once a day for 2, 5 or 8 days) to male rats decreased γ-aminobutyric acid (GABA) content and glutamate decarboxylase (GAD) activity in substantia nigra (SN) but failed to change these parameters in hippocampus, cerebral cortex, cerebellum, lateral septum and olfactory tubercle. In the caudate nucleus, estradiol benzoate decreased GABA concentration but did not modify GAD activity. A decrease in nigral GABA concentration and GAD activity was also observed 24 and 48 but not 3 h after a single injection of estradiol benzoate. These data are consistent with results on GAD activity reported by McGinnis et al.26 in ovariectomized rats. Kinetic analysis of nigral GAD activity revealed that repeated estradiol benzoate injection reduced the Vmax without affecting the Km of GAD. Estradiol benzoate also reduced the rate of nigral GABA accumulation resulting from local infusion of gabaculine, suggesting that the steroid decreases GABA turnover in male rat SN. Hypophysectomy decreased GABA content and GAD activity in SN and GABA content in striatum. Administration of estradiol benzoate for 8 days to hypophysectomized rats failed to decrease further these parameters. Taken together, these data suggest that estradiol benzoate decreases SN GABAergic activity and that the integrity of the pituitary gland is required for this effect.

AB - Repeated doses of estradiol benzoate (10 μg/kg, s.c., once a day for 2, 5 or 8 days) to male rats decreased γ-aminobutyric acid (GABA) content and glutamate decarboxylase (GAD) activity in substantia nigra (SN) but failed to change these parameters in hippocampus, cerebral cortex, cerebellum, lateral septum and olfactory tubercle. In the caudate nucleus, estradiol benzoate decreased GABA concentration but did not modify GAD activity. A decrease in nigral GABA concentration and GAD activity was also observed 24 and 48 but not 3 h after a single injection of estradiol benzoate. These data are consistent with results on GAD activity reported by McGinnis et al.26 in ovariectomized rats. Kinetic analysis of nigral GAD activity revealed that repeated estradiol benzoate injection reduced the Vmax without affecting the Km of GAD. Estradiol benzoate also reduced the rate of nigral GABA accumulation resulting from local infusion of gabaculine, suggesting that the steroid decreases GABA turnover in male rat SN. Hypophysectomy decreased GABA content and GAD activity in SN and GABA content in striatum. Administration of estradiol benzoate for 8 days to hypophysectomized rats failed to decrease further these parameters. Taken together, these data suggest that estradiol benzoate decreases SN GABAergic activity and that the integrity of the pituitary gland is required for this effect.

KW - estradiol benzoate

KW - gabaculine

KW - glutamate decarboxylase (GAD) activity

KW - hypophysectomy

KW - substantia nigra

KW - γ-aminobutyric acid (GABA) activity

UR - http://www.scopus.com/inward/record.url?scp=0021925252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021925252&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(85)90404-4

DO - 10.1016/0006-8993(85)90404-4

M3 - Article

C2 - 2986760

AN - SCOPUS:0021925252

VL - 332

SP - 179

EP - 183

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -